MyoKardia (MYOK) PT Raised to $87 at Morgan Stanley
Tweet
Share
E-mailGet Alerts MYOK Hot Sheet
Price: $224.91 --0%
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
4 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on MyoKardia (NASDAQ: MYOK) to $87.00 (from $83.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- VersaBank (VBNK) PT Lowered to $20 at Raymond James
- CLSA Downgrades Heineken Malaysia Bhd (HEIM:MK) to Hold (3)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
